What is the persistence rate of secondary prevention medications 3 months after acute ischemic stroke or TIA?
A significant proportion (almost one-third) of AIS/TIA patients in China discontinue secondary prevention medications within 3 months of discharge, highlighting a need for interventions to improve adherence.
Almost one-third of patients of AIS/TIA had stopped one or more secondary prevention medications by 3-month postdischarge. Further studies on identifying potential barriers and means to improve persistent use of secondary prevention interventions are needed.
Ji et al. (Tue,) studied this question.